Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jeffrey T. Guptill, John W. Sleasman, Sophie Steeland, Magdalena Sips, Deborah Gelinas, Hans de Haard, Antoine Azar & Kevin L. Winthrop. (2022) Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis. Autoimmunity 55:8, pages 620-631.
Read now
Read now
Indraneel Basu, Manish Agarwal, Viral Shah, Vijay Shukla, Sunil Naik, Pravin Dinkar Supe, Manoj Kumar Srivastava, Kanakapura Vrushabaiah Giriraja, Peersab Pinjar, Pradeep Kumar Mishra, Shishir Joshi, Ranjit Vijayakumar & Serge van de Witte. (2022) Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study. Human Vaccines & Immunotherapeutics 18:1, pages 1-10.
Read now
Read now
Simin Wen, Zhengyu Wu, Shuyi Zhong, Mao Li & Yuelong Shu. (2021) Factors influencing the immunogenicity of influenza vaccines. Human Vaccines & Immunotherapeutics 17:8, pages 2706-2718.
Read now
Read now
Thomas Verstraeten, Mark A. Fletcher, Jose A. Suaya, Sally Jackson, Cassandra K. Hall-Murray, Daniel A. Scott, Beate Schmöle-Thoma, Raul E. Isturiz & Bradford D. Gessner. (2020) Diabetes mellitus as a vaccine-effect modifier: a review. Expert Review of Vaccines 19:5, pages 445-453.
Read now
Read now
Susanna Esposito. (2018) 100 years since the 1918 influenza pandemic. Human Vaccines & Immunotherapeutics 14:3, pages 504-507.
Read now
Read now
Articles from other publishers (46)
Qiuyi Xu, Hejiang Wei, Simin Wen, Jiamin Chen, Yuxuan Lei, Yanhui Cheng, Weijuan Huang, Dayan Wang & Yuelong Shu. (2023) Factors affecting the immunogenicity of influenza vaccines in human. BMC Infectious Diseases 23:1.
Crossref
Crossref
Matthew Z. Dudley, Jennifer E. Gerber, Haley Budigan Ni, Madeleine Blunt, Taylor A. Holroyd, Bruce C. Carleton, Gregory A. Poland & Daniel A. Salmon. (2023) Vaccinomics: A scoping review. Vaccine 41:14, pages 2357-2367.
Crossref
Crossref
Prabda Praphasiri, Kriengkrai Prasert, Manash Shrestha, Darunee Ditsungnoen, Malinee Chittaganpich, Sutthinan Chawalchitiporn, Fatimah S. Dawood, Supakit Sirilak & Joshua A. Mott. (2023) Does prior vaccination affect the immune response to seasonal influenza vaccination among older adults? Findings from a prospective cohort study in a Northeastern Province of Thailand. PLOS ONE 18:2, pages e0279962.
Crossref
Crossref
Peggy Riese, Stephanie Trittel, Manas K. Akmatov, Marcus May, Jana Prokein, Thomas Illig, Christoph Schindler, Birgit Sawitzki, Yassin Elfaki, Stefan Floess, Jochen Huehn, Adrian J. Błażejewski, Till Strowig, Esteban A. Hernandez-Vargas, Robert Geffers, Bowen Zhang, Yang Li, Frank Pessler & Carlos A. Guzmán. (2022) Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly. Nature Communications 13:1.
Crossref
Crossref
Daniela Frasca. (2022) Several areas of overlap between obesity and aging indicate obesity as a biomarker of accelerated aging of human B cell function and antibody responses. Immunity & Ageing 19:1.
Crossref
Crossref
Paraskevi C. Fragkou, Charalampos D. Moschopoulos, Rieke Reiter, Thilo Berger & Chrysanthi Skevaki. (2022) Host immune responses and possible therapeutic targets for viral respiratory tract infections in susceptible populations: a narrative review. Clinical Microbiology and Infection 28:10, pages 1328-1334.
Crossref
Crossref
Constantina Boikos, Ian McGovern, Justin R. Ortiz, Joan Puig-Barberà, Eve Versage & Mendel Haag. (2022) Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States. Vaccines 10:9, pages 1456.
Crossref
Crossref
Artur Capão, Maria Aguiar-Oliveira, Braulia Caetano, Thayssa Neves, Paola Resende, Walquiria Almeida, Milene Miranda, Olindo Martins-Filho, David Brown, Marilda Siqueira & Cristiana Garcia. (2022) Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil. Viruses 14:8, pages 1692.
Crossref
Crossref
Zorana M. Djordjević, Jagoda Gavrilović, Romana Suša, Ana V. Pejčić, Biljana Popovska-Jovičić, Predrag Čanović, Radica S. Živković-Zarić, Miloš N. Milosavljević, Valentina D. Opančina, Ivana K. Petrović, Ivan Čekerevac, Zorica Lazić, Marko M. Folić, Ljiljana Novković & Slobodan M. Janković. (2022) Factors Associated with Death of Covid-19 Patients: Case Series. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Crossref
Yang Wang, Cynthia Y. Tang & Xiu-Feng Wan. (2021) Antigenic characterization of influenza and SARS-CoV-2 viruses. Analytical and Bioanalytical Chemistry 414:9, pages 2841-2881.
Crossref
Crossref
Daniel A. Norman, Allen C. Cheng, Kristine K. Macartney, Hannah C. Moore, Margie Danchin, Holly Seale, Jocelynne McRae, Julia E. Clark, Helen S. Marshall, Jim Buttery, Joshua R. Francis, Nigel W. Crawford & Christopher C. Blyth. (2021) Influenza hospitalizations in Australian children 2010–2019: The impact of medical comorbidities on outcomes, vaccine coverage, and effectiveness. Influenza and Other Respiratory Viruses 16:2, pages 316-327.
Crossref
Crossref
Savannah A Moritzky, Katherine A Richards, Maryah A Glover, Florian Krammer, Francisco A Chaves, David J Topham, Angela Branche, Jennifer L Nayak & Andrea J Sant. (2022) The Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History. The Journal of Infectious Diseases.
Crossref
Crossref
Shuyi Zhong, Hejiang Wei, Mao Li, Yanhui Cheng, Simin Wen, Dayan Wang & Yuelong Shu. (2022) Single Nucleotide Polymorphisms in the Human Leukocyte Antigen Region Are Associated With Hemagglutination Inhibition Antibody Response to Influenza Vaccine. Frontiers in Genetics 13.
Crossref
Crossref
Mingmei Tian, Jihnhee Yu, Denise F. Lillvis & Albert Vexler. (2021) Influence function methods to assess the effectiveness of influenza vaccine with survey data. Health Services Research 57:1, pages 200-211.
Crossref
Crossref
Chien-Chang Liao, Ying-Hsuan Tai, Chun-Chieh Yeh, Yung-Ho Hsu, Ta-Liang Chen & Yih-Giun Cherng. (2022) Effect of influenza vaccination on the outcomes of hospitalization for kidney disease in a geriatric population: A propensity-score matched study. PLOS ONE 17:1, pages e0262420.
Crossref
Crossref
V. Z. Krivitskaya, E. V. Kuznecova, V. G. Maiorova, E. R. Petrova, A. A. Sominina & D. M. Danilenko. (2022) Influenza vaccination influencing level of specific humoral immunity in healthy individuals. Russian Journal of Infection and Immunity 12:1, pages 127-141.
Crossref
Crossref
Daniela Frasca. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System
65
90
.
Yun‐Hee Kim, Kee‐Jong Hong, Hun Kim & Jae‐Hwan Nam. (2021) Influenza vaccines: Past, present, and future. Reviews in Medical Virology 32:1.
Crossref
Crossref
Håkon Amdam, Anders Madsen, Fan Zhou, Amit Bansal, Mai-Chi Trieu & Rebecca Jane Cox. (2021) Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014). Frontiers in Immunology 12.
Crossref
Crossref
Luca Hensen, Thi H. O. Nguyen, Louise C. Rowntree, Timon DamelangMarios Koutsakos, Malet AbanAeron HurtKim L. HarlandMaria AuladellCarolien E. van de Sandt, Anngie EverittCath BlackerDamian A. OyongJessica R. LoughlandJessica R. WebbBruce D. WinesP. Mark HogarthKatie L. Flanagan, Magdalena PlebanskiAdam Wheatley, Amy W. Chung, Stephen J. Kent, Adrian MillerE. Bridie ClemensPeter C. DohertyJane NelsonJane DaviesSteven Y. C. Tong & Katherine Kedzierska. (2021) Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians. Proceedings of the National Academy of Sciences 118:41.
Crossref
Crossref
Ausenda Machado, Andreia Leite, Amparo Larrauri, Verónica Gomez, Ana Paula Rodrigues, Irina Kislaya & Baltazar Nunes. (2021) No effect modification of influenza virus vaccine effectiveness by age or chronic condition was observed in the 2010/11 to 2017/18 seasons. Pharmacoepidemiology and Drug Safety 30:10, pages 1411-1419.
Crossref
Crossref
Constantina Boikos, Lauren Fischer, Dan O’Brien, Joe Vasey, Gregg C Sylvester & James A Mansi. (2021) Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenza Seasons. Clinical Infectious Diseases 73:5, pages 816-823.
Crossref
Crossref
Abed Agbarya, Ina Sarel, Tomer Ziv-Baran, Sivan Agranat, Orna Schwartz, Ayelet Shai, Sharon Nordheimer, Shlomit Fenig, Yelena Shechtman, Ella Kozlener, Tarek Taha, Haitam Nasrallah, Roma Parikh, Nadav Elkoshi, Carmit Levy, Rasha Khoury & Ronen Brenner. (2021) Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs. Cancers 13:16, pages 4191.
Crossref
Crossref
Constantina Boikos, Mahrukh Imran, Van Hung Nguyen, Thierry Ducruet, Gregg C. Sylvester & James A. Mansi. (2021) Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications. Vaccines 9:8, pages 862.
Crossref
Crossref
Michelle Clarke, Louise M. Goodchild, Sue Evans, Lynne C. Giles, Sheena G. Sullivan, Ian G. Barr, Stephen Lambert & Helen Marshall. (2021) Body mass index and vaccine responses following influenza vaccination during pregnancy. Vaccine 39:34, pages 4864-4870.
Crossref
Crossref
Joanna Kimball, Yuwei Zhu, Dayna Wyatt, Christopher H Trabue & H Keipp Talbot. (2021) Influenza Vaccine Failure Associated With Age and Immunosuppression. The Journal of Infectious Diseases 224:2, pages 288-293.
Crossref
Crossref
Jiří Beran, Humberto Reynales, Airi Poder, Charles Y Yu, Punnee Pitisuttithum, Lee Li Yuan, Wim Vermeulen, Carole Verhoeven, Brett Leav, Bin Zhang, Daphne Sawlwin, Esther Hamers-Heijnen, Jonathan Edelman & Igor Smolenov. (2021) Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study. The Lancet Infectious Diseases 21:7, pages 1027-1037.
Crossref
Crossref
Nancy S Jecker, Aaron G Wightman & Douglas S Diekema. (2021) Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines. Journal of Medical Ethics, pages medethics-2020-107036.
Crossref
Crossref
Yoonsun Yoon, Joon-sik Choi, MiRan Park, Hyun Cho, Minsu Park, Hee Jae Huh, Yae-Jean Kim & Meong Hi Son. (2021) Influenza Vaccine Effectiveness in Children at the Emergency Department during the 2018-2019 Season: the First Season School-aged Children Were Included in the Korean Influenza National Immunization Program. Journal of Korean Medical Science 36:10.
Crossref
Crossref
Heidi A. Hanson, Claire L. Leiser, Gretchen Bandoli, Brad H. Pollock, Margaret R. Karagas, Daniel Armstrong, Ann Dozier, Nicole G. Weiskopf, Maureen Monaghan, Ann M. Davis, Elizabeth Eckstrom, Chunhua Weng, Jonathan N. Tobin, Frederick Kaskel, Mark R. Schleiss, Peter Szilagyi, Carrie Dykes, Dan Cooper & Shari L. Barkin. (2020) Charting the life course: Emerging opportunities to advance scientific approaches using life course research. Journal of Clinical and Translational Science 5:1.
Crossref
Crossref
AbdulAzeez A. Anjorin & Barakat A. Adepoju. (2020) Serologic evidence of seasonal influenza A and B in HIV patients on combined antiretroviral therapy in Lagos, Nigeria. African Journal of Laboratory Medicine 9:1.
Crossref
Crossref
Daniela Frasca & Bonnie B. Blomberg. (2020) Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination. Immunity & Ageing 17:1.
Crossref
Crossref
Daniela Frasca, Alain DiazMaria RomeroDenisse GarciaBonnie B. Blomberg. (2020) B Cell Immunosenescence. Annual Review of Cell and Developmental Biology 36:1, pages 551-574.
Crossref
Crossref
Dianming Li, Chuanmiao Liu, Jiahui Liu, Junfeng Hu, Yanli Yang & Yufu Zhou. (2020) Analysis of Risk Factors for 24 Patients With COVID-19 Developing From Moderate to Severe Condition. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Nataliia O. Pryimenko, Tetiana M. Kotelevska, Tetiana I. Koval, Vadym A. Bodnar, Liudmyla M. Syzova & Stanislav S. Rudenko. (2020) EFFICACY OF SPECIFIC PREVENTION OF INFLUENZA IN INDIVIDUALS WITH POLYMORPHISMS ARG753GLN OF TLR-2, LEU412PHE OF TLR-3, ASP299GLY OF TLR-4 GENES. Wiadomości Lekarskie 73:9, pages 1944-1949.
Crossref
Crossref
Peishan Qiu, Yunjiao Zhou, Fan Wang, Haizhou Wang, Meng Zhang, Xingfei Pan, Qiu Zhao & Jing Liu. (2020) Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clinical and Experimental Research 32:9, pages 1869-1878.
Crossref
Crossref
Jeffrey Baker, Stanley L. Block, Balpreet Matharu, Laura Burleigh Macutkiewicz, Steffen Wildum, Sophie Dimonaco, Neil Collinson, Barry Clinch & Pedro A. Piedra. (2020) Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children. Pediatric Infectious Disease Journal 39:8, pages 700-705.
Crossref
Crossref
Zhaohai Zheng, Fang Peng, Buyun Xu, Jingjing Zhao, Huahua Liu, Jiahao Peng, Qingsong Li, Chongfu Jiang, Yan Zhou, Shuqing Liu, Chunji Ye, Peng Zhang, Yangbo Xing, Hangyuan Guo & Weiliang Tang. (2020) Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of Infection 81:2, pages e16-e25.
Crossref
Crossref
Daniela Frasca, Bonnie B. Blomberg, Denisse Garcia, Spencer R. Keilich & Laura Haynes. (2020) Age‐related factors that affect B cell responses to vaccination in mice and humans. Immunological Reviews 296:1, pages 142-154.
Crossref
Crossref
Biljana Bufan, Nevena Arsenović-Ranin, Raisa Petrović, Irena Živković, Vera Stoiljković & Gordana Leposavić. (2020) Strain specificities in influence of ageing on germinal centre reaction to inactivated influenza virus antigens in mice: Sex-based differences. Experimental Gerontology 133, pages 110857.
Crossref
Crossref
Georgios DougasMaria MavrouliGeorgia VrioniTheodore LytrasKassiani MellouSymeon MetallidisIoannis IstikoglouKonstantinos MitrouMyrsini TzaniIoanna GeorgopoulouFoteini TsalikoglouEleni GaretsouGaryfallia PoulakouEfthymia GiannitsiotiCharalampos MoschopoulosAgoritsa BakaTheano GeorgakopoulouSotirios TsiodrasAthanassios Tsakris. (2020) Antibody Response Following Pre-Exposure Immunization Against Rabies in High-Risk Professionals. Vector-Borne and Zoonotic Diseases 20:4, pages 303-309.
Crossref
Crossref
Alexander Domnich, Ilaria Manini, Giovanna Elisa Calabrò, Chiara de Waure & Emanuele Montomoli. (2019) Mapping Host-Related Correlates of Influenza Vaccine-Induced Immune Response: An Umbrella Review of the Available Systematic Reviews and Meta-Analyses. Vaccines 7:4, pages 215.
Crossref
Crossref
Breanna Hodgins, Stephane Pillet, Nathalie Landry & Brian J. Ward. (2019) Prime-pull vaccination with a plant-derived virus-like particle influenza vaccine elicits a broad immune response and protects aged mice from death and frailty after challenge. Immunity & Ageing 16:1.
Crossref
Crossref
Maria Ganczak, Paulina Dubiel, Marzena Drozd-Dąbrowska, Ewelina Hallmann-Szelińska, Karol Szymański & Lidia B. Brydak. (2019) Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season. International Journal of Environmental Research and Public Health 16:22, pages 4489.
Crossref
Crossref
Lavida R. K. Rogers, Gustavo de los Campos & George I. Mias. (2019) Microarray Gene Expression Dataset Re-analysis Reveals Variability in Influenza Infection and Vaccination. Frontiers in Immunology 10.
Crossref
Crossref
Nancy Law & Deepali Kumar. (2017) Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management. Drugs & Aging 34:10, pages 743-754.
Crossref
Crossref